Lv1
10 积分 2024-09-22 加入
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
20小时前
已完结
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
5个月前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
6个月前
已完结
皖公网安备34019202002308
